Optics.org
daily coverage of the optics & photonics industry and the markets that it serves
Featured Showcases
Defense+Commercial Sensing Showcase
News
Menu
Corneal implant
ReVision Optics is set to perform an evaluation of the tiny implantable lens on 400 subjects over the course of the three-year FDA trial. Credits: iStockphoto/RVO.
© 2023 SPIE Europe
Top of Page